Suppr超能文献

在低铁环境中,M14659的杀菌活性增强。

Bactericidal activity of M14659 enhanced in low-iron environments.

作者信息

Mochizuki H, Yamada H, Oikawa Y, Murakami K, Ishiguro J, Kosuzume H, Aizawa N, Mochida E

机构信息

Fuji Central Research Laboratory, Mochida Pharmaceutical Co., Ltd., Shizuoka, Japan.

出版信息

Antimicrob Agents Chemother. 1988 Nov;32(11):1648-54. doi: 10.1128/AAC.32.11.1648.

Abstract

The bactericidal activity of M14659 against Escherichia coli in low-iron environments was investigated and compared with that of ceftriaxone and ceftazidime. The bactericidal activity of M14659 against E. coli in Mueller-Hinton broth was enhanced 30- to 20,000-fold by addition of transferrin, which is an iron-binding protein, whereas the activity of ceftriaxone or ceftazidime was much less strongly affected. This enhancement by transferrin was completely inhibited by saturating the iron-binding capacity of transferrin with FeCl3. M14659 was taken up markedly into bacterial cells in the presence of transferrin, and its uptake was inhibited by the protonophore dinitrophenol, which inhibits active-transport systems coupled to an energized membrane such as the iron transport systems of E. coli. The bactericidal activity of M14659, which chelates Fe3+, was also enhanced in the presence of other iron-binding compounds such as lactoferrin and alpha,alpha'-dipyridyl or in iron-deficient Mueller-Hinton broth (Fe3+ concentration, less than 2 nM) supplemented with FeCl3 at 0.1 to 1.0 microM, but not in unsupplemented iron-deficient Mueller-Hinton broth. The E. coli used in this study was confirmed to derepress iron transport systems in the presence of transferrin, lactoferrin, and alpha,alpha'-dipyridyl and in the iron-deficient Mueller-Hinton broth supplemented with FeCl3 at 0 to 1.0 microM. M14659 also showed an excellent antibacterial activity in vitro against other gram-negative bacteria in the low-iron environments. These findings indicate that M14659 may be actively taken up with Fe3+ into bacterial cells, probably through the iron transport systems under conditions of low iron and, thus, kills bacteria effectively.

摘要

研究了M14659在低铁环境中对大肠杆菌的杀菌活性,并与头孢曲松和头孢他啶进行了比较。在穆勒-欣顿肉汤中,添加铁结合蛋白转铁蛋白可使M14659对大肠杆菌的杀菌活性提高30至20000倍,而头孢曲松或头孢他啶的活性受影响程度则小得多。用FeCl3使转铁蛋白的铁结合能力饱和后,转铁蛋白的这种增强作用被完全抑制。在有转铁蛋白存在的情况下,M14659可显著被细菌细胞摄取,其摄取受到质子载体二硝基苯酚的抑制,二硝基苯酚可抑制与能量化膜偶联的主动转运系统,如大肠杆菌的铁转运系统。螯合Fe3+的M14659的杀菌活性在存在其他铁结合化合物(如乳铁蛋白和α,α'-联吡啶)时,或在添加了0.1至1.0 microM FeCl3的缺铁穆勒-欣顿肉汤(Fe3+浓度小于2 nM)中也会增强,但在未添加的缺铁穆勒-欣顿肉汤中则不会。本研究中使用的大肠杆菌在存在转铁蛋白、乳铁蛋白和α,α'-联吡啶以及添加了0至1.0 microM FeCl3的缺铁穆勒-欣顿肉汤中被证实可解除对铁转运系统的抑制。M14659在体外对低铁环境中的其他革兰氏阴性菌也表现出优异的抗菌活性。这些发现表明,M14659可能在低铁条件下通过铁转运系统与Fe3+一起被主动摄取到细菌细胞中,从而有效杀死细菌。

相似文献

1
Bactericidal activity of M14659 enhanced in low-iron environments.
Antimicrob Agents Chemother. 1988 Nov;32(11):1648-54. doi: 10.1128/AAC.32.11.1648.
2
Antibacterial and pharmacokinetic properties of M14659, a new injectable semisynthetic cephalosporin.
J Antibiot (Tokyo). 1988 Mar;41(3):377-91. doi: 10.7164/antibiotics.41.377.
3
E-0702, a new cephalosporin, is incorporated into Escherichia coli cells via the tonB-dependent iron transport system.
Antimicrob Agents Chemother. 1987 Apr;31(4):497-504. doi: 10.1128/AAC.31.4.497.
4
Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilli.
Antimicrob Agents Chemother. 1989 Jan;33(1):35-40. doi: 10.1128/AAC.33.1.35.
5
Enhancement of the activity of novobiocin against Escherichia coli by lactoferrin.
J Dairy Sci. 1999 Mar;82(3):494-9. doi: 10.3168/jds.S0022-0302(99)75259-8.
7
Prooxidant activity of transferrin and lactoferrin.
J Exp Med. 1990 Nov 1;172(5):1293-303. doi: 10.1084/jem.172.5.1293.
8
Influence of bacterial beta-lactamase production on susceptibility in agar or broth to new cephalosporins.
J Antimicrob Chemother. 1981 Sep;8 Suppl B:153-62. doi: 10.1093/jac/8.suppl_b.153.
10
Synergism between iron chelators and complement for bactericidal activity.
Ann Immunol (Paris). 1983 Jan-Feb;134C(1):25-30. doi: 10.1016/s0769-2625(83)80150-0.

引用本文的文献

1
Siderophores as tools and treatments.
NPJ Antimicrob Resist. 2024;2(1):47. doi: 10.1038/s44259-024-00053-4. Epub 2024 Dec 5.
2
Siderophore conjugates to combat antibiotic-resistant bacteria.
RSC Med Chem. 2023 Mar 1;14(5):800-822. doi: 10.1039/d2md00465h. eCollection 2023 May 25.
3
Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin.
Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S538-S543. doi: 10.1093/cid/ciz826.
5
Design, synthesis and microbiological evaluation of ampicillin-tetramic acid hybrid antibiotics.
J Antibiot (Tokyo). 2017 Jan;70(1):65-72. doi: 10.1038/ja.2016.52. Epub 2016 May 18.
6
Enterobactin-mediated delivery of β-lactam antibiotics enhances antibacterial activity against pathogenic Escherichia coli.
J Am Chem Soc. 2014 Jul 9;136(27):9677-91. doi: 10.1021/ja503911p. Epub 2014 Jun 27.
7
In vitro and in vivo activities of Syn2190, a novel beta-lactamase inhibitor.
Antimicrob Agents Chemother. 1999 Aug;43(8):1895-900. doi: 10.1128/AAC.43.8.1895.
8
Growth of Actinobacillus pleuropneumoniae is promoted by exogenous hydroxamate and catechol siderophores.
Appl Environ Microbiol. 1996 Mar;62(3):853-9. doi: 10.1128/aem.62.3.853-859.1996.
9
Species selectivity of new siderophore-drug conjugates that use specific iron uptake for entry into bacteria.
Antimicrob Agents Chemother. 1996 Nov;40(11):2610-7. doi: 10.1128/AAC.40.11.2610.
10
In vitro and in vivo activities of LB10522, a new catecholic cephalosporin.
Antimicrob Agents Chemother. 1996 Aug;40(8):1825-31. doi: 10.1128/AAC.40.8.1825.

本文引用的文献

1
The significance of iron in infection.
Rev Infect Dis. 1981 Nov-Dec;3(6):1127-38. doi: 10.1093/clinids/3.6.1127.
2
Iron transport and storage proteins.
Annu Rev Biochem. 1980;49:357-93. doi: 10.1146/annurev.bi.49.070180.002041.
4
Enhancement of Neisseria meningitidis infection in mice by addition of iron bound to transferrin.
Infect Immun. 1981 Oct;34(1):120-5. doi: 10.1128/iai.34.1.120-125.1981.
5
Microbial iron compounds.
Annu Rev Biochem. 1981;50:715-31. doi: 10.1146/annurev.bi.50.070181.003435.
6
Antimicrobial properties of iron-binding proteins.
Adv Exp Med Biol. 1981;135:139-54. doi: 10.1007/978-1-4615-9200-6_8.
8
Iron-controlled infection with Neisseria meningitidis in mice.
Infect Immun. 1980 Sep;29(3):886-91. doi: 10.1128/iai.29.3.886-891.1980.
9
Antibacterial and pharmacokinetic properties of M14659, a new injectable semisynthetic cephalosporin.
J Antibiot (Tokyo). 1988 Mar;41(3):377-91. doi: 10.7164/antibiotics.41.377.
10
The role of iron in infection.
Med Lab Sci. 1985 Apr;42(2):166-77.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验